Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery
about
Alpha-fetoprotein-targeted reporter gene expression imaging in hepatocellular carcinomaThe use of the NIS reporter gene for optimizing oncolytic virotherapyBeyond non-integer Hill coefficients: A novel approach to analyzing binding data, applied to Na+-driven transporters.In vitro radionuclide therapy and in vivo scintigraphic imaging of alpha-fetoprotein-producing hepatocellular carcinoma by targeted sodium iodide symporter gene expression.Imaging and targeted therapy of pancreatic ductal adenocarcinoma using the theranostic sodium iodide symporter (NIS) geneSodium iodide symporter (NIS)-mediated radiovirotherapy of hepatocellular cancer using a conditionally replicating adenovirus.Codon-optimized human sodium iodide symporter (opt-hNIS) as a sensitive reporter and efficient therapeutic gene.Assessment of α-fetoprotein targeted HSV1-tk expression in hepatocellular carcinoma with in vivo imaging.Image-guided tumor-selective radioiodine therapy of liver cancer after systemic nonviral delivery of the sodium iodide symporter gene.Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cellsEfficient multicistronic co-expression of hNIS and hTPO in prostate cancer cells for nonthyroidal tumor radioiodine therapy.Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy.The Na+/I- symporter (NIS): mechanism and medical impact.Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery.Cancer imaging: Gene transcription-based imaging and therapeutic systems.Sequence-defined cMET/HGFR-targeted Polymers as Gene Delivery Vehicles for the Theranostic Sodium Iodide Symporter (NIS) Gene.Cerenkov Radiation Induced Photodynamic Therapy Using Chlorin e6-Loaded Hollow Mesoporous Silica Nanoparticles.Harnessing mesenchymal stem cell homing as an anticancer therapy.Small activating RNA upregulates NIS expression: promising potential for hepatocellular carcinoma endoradiotherapy.EGFR-Targeted Adenovirus Dendrimer Coating for Improved Systemic Delivery of the Theranostic NIS GeneEstablishment of an Effective Radioiodide Thyroid Ablation Protocol in Mice.EGFR-targeted nonviral NIS gene transfer for bioimaging and therapy of disseminated colon cancer metastases.Systemic tumor-targeted sodium iodide symporter (NIS) gene therapy of hepatocellular carcinoma mediated by B6 peptide polyplexes.EGFR Targeting and Shielding of pDNA Lipopolyplexes via Bivalent Attachment of a Sequence-Defined PEG Agent.Novel PAMAM-PEG-Peptide Conjugates for siRNA Delivery Targeted to the Transferrin and Epidermal Growth Factor Receptors.
P2860
Q26741197-D41C2828-E6B6-46FF-A666-F4CA575DE808Q28083534-A854CF80-A642-409C-B066-F24B39CCD9F6Q30958355-7C09CFEE-749E-4169-9DEC-A74F78993924Q33670033-6D00B826-9100-4CE1-8A86-6615EB1A27D4Q33779491-006F3A74-4CB2-4A60-B4C5-1C7780500A7FQ34303955-01C20287-FE79-4D94-B644-91930AC0F197Q34698684-35149E39-5CB2-4BB5-9359-E3EC00C408D0Q35068110-7B6766D5-E11B-4117-BBEE-14B2134D517CQ35612571-5EBB8AF0-F8B4-4E93-815B-4323F8654FDDQ35728290-695C27D3-CC1F-4D1B-89BF-7478339DC6AAQ36357754-764536E2-9C3B-4D02-B21D-894A84038BB6Q36720696-EAFD8B44-1977-436A-8F4E-21AB85D017E1Q37031758-EE1459FB-40DF-4341-85C6-F53239CB40EAQ37494004-3671D80A-A328-44ED-9A13-6938896C7EDBQ37688142-26AF8106-3338-4D93-8803-D79D6647C0E6Q37986315-EE186A49-40F3-43D3-ACA7-FA79C7B8E74CQ38772380-0E75DAC7-23EB-42B7-B837-88AF8CB3BFCDQ38818714-5ABEEAA9-176E-48FC-8A43-B0F026BFC427Q38857484-90190A02-DADC-4425-9440-5D7D793163A9Q40485794-AEF526FE-3989-4CA9-AA1F-AC99248F71F5Q41866984-30F8BA30-BF59-4879-92A1-6908E1A6B0A7Q42127600-6B3AC6B3-9878-41F5-97F2-2F829C4FB773Q45326571-6C1E601C-E9FE-4618-9A3A-60DF7B937264Q45866837-D2CFDA4C-36EC-41FA-8E77-BDEBFC426E62Q48119581-19A6000C-17F7-4C5B-9123-8547269945F6Q48284313-352A7746-9840-45E5-B2A5-9A83AF286246
P2860
Sodium iodide symporter (NIS)-mediated radionuclide ((131)I, (188)Re) therapy of liver cancer after transcriptionally targeted intratumoral in vivo NIS gene delivery
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Sodium iodide symporter (NIS)- ...... oral in vivo NIS gene delivery
@ast
Sodium iodide symporter (NIS)- ...... oral in vivo NIS gene delivery
@en
type
label
Sodium iodide symporter (NIS)- ...... oral in vivo NIS gene delivery
@ast
Sodium iodide symporter (NIS)- ...... oral in vivo NIS gene delivery
@en
prefLabel
Sodium iodide symporter (NIS)- ...... oral in vivo NIS gene delivery
@ast
Sodium iodide symporter (NIS)- ...... oral in vivo NIS gene delivery
@en
P2093
P2860
P356
P1433
P1476
Sodium iodide symporter (NIS)- ...... oral in vivo NIS gene delivery
@en
P2093
Burkhard Göke
Christian Zach
Christine Spitzweg
Kathrin Klutz
Martina Anton
Michael J Willhauck
Nathalie Wunderlich
Reingard Senekowitsch-Schmidtke
P2860
P304
P356
10.1089/HUM.2010.158
P577
2011-06-28T00:00:00Z